NewGLAB Pharma CO.,LTD Stock

Equities

A214870

KR7214870008

Phones & Handheld Devices

End-of-day quote Korea S.E. 06:00:00 2023-03-08 pm EST 5-day change 1st Jan Change
1,383 KRW -27.44% Intraday chart for NewGLAB Pharma CO.,LTD -.--% -.--%
Sales 2022 21.71B 15.81M Sales 2023 12.62B 9.19M Capitalization 45.81B 33.35M
Net income 2022 -69.55B -50.63M Net income 2023 1.99B 1.45M EV / Sales 2022 18.3 x
Net Debt 2022 26.68B 19.42M Net Debt 2023 32.42B 23.6M EV / Sales 2023 6.2 x
P/E ratio 2022
-5.2 x
P/E ratio 2023
23 x
Employees 16
Yield 2022 *
-
Yield 2023
-
Free-Float 96.69%
More Fundamentals * Assessed data
Dynamic Chart
NewGLAB Pharma CO.,LTD announced that it has received KRW 6.835 billion in funding from Namhwa Corporation, SLP Co. Ltd. and other investors CI
NewGLAB Pharma CO.,LTD announced that it expects to receive KRW 6.835 billion in funding from Namhwa Corporation, SLP Co. Ltd. and other investors CI
NewGLAB Pharma CO.,LTD(KOSDAQ:A214870) dropped from S&P Global BMI Index CI
NewGLAB Pharma CO.,LTD Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
NewGLAB Pharma CO.,LTD announced that it has received KRW 25 billion in funding from DB Financial Investment Co.,Ltd., Investment Arm CI
NewGLAB Pharma CO.,LTD announced that it expects to receive KRW 35 billion in funding from DB Financial Investment Co.,Ltd., Investment Arm CI
NewGLAB CO.,LTD announced that it has received KRW 9.23 billion in funding CI
NewGLAB CO.,LTD announced that it expects to receive KRW 9.23 billion in funding CI
NewGLAB CO.,LTD announced that it has received KRW 35 billion in funding from DB Financial Investment Co.,Ltd., Investment Arm CI
NewGLAB CO.,LTD announced that it expects to receive KRW 35 billion in funding from DB Financial Investment Co.,Ltd., Investment Arm CI
NewGLAB CO.,LTD announced that it has received KRW 18 billion in funding CI
NewGLAB CO.,LTD announced that it expects to receive KRW 18 billion in funding CI
NewGLAB CO.,LTD(KOSDAQ:A214870) added to S&P Global BMI Index CI
NewGLAB CO.,LTD announced that it has received KRW 15 billion in funding from DB Financial Investment Co.,Ltd., Investment Arm CI
An unknown buyer acquired 3.8% stake in NewGLAB CO.,LTD from Ahrenel International. CI
More news
3 years
1 356.00
Extreme 1356
15 050.00
5 years
1 356.00
Extreme 1356
19 450.00
10 years
1 356.00
Extreme 1356
19 450.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 55 -
Comptroller/Controller/Auditor 57 -
Members of the board TitleAgeSince
Director/Board Member 51 19-01-03
Director/Board Member 57 19-01-03
Chief Executive Officer 55 -
More insiders
NewGLab Pharma Co Ltd, formerly NewGLab Co Ltd, is a company mainly engaged in the manufacturing and sale of closed-circuit television (CCTV) cameras. The Company's product portfolio consists of general analog cameras that used for CCTVs, high definition (HD) analog cameras, HD-serial digital interface (SDI) cameras, extend (EX)-SDI cameras, internet protocol (IP) cameras that used for network CCTVs, digital video recorders (DVRs) that used for image storage devices, network video recorders (NVRs) and others. In addition, the Company is involved in the business of 5G smartphone distribution. The Company distributes its products within domestic market and to overseas markets.
More about the company
  1. Stock Market
  2. Equities
  3. A214870 Stock